The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: ...

After losing some value lately, a hammer chart pattern has been formed for Soleno Therapeutics (SLNO), indicating that the ...

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. ("Soleno" or the ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) ...

Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...

Why the latest JCEM publication matters for Soleno Therapeutics (SLNO) Soleno Therapeutics (SLNO) is back in focus after a ...

Indian American physician to help accelerate commercial readiness for biotechnology firm’s cell therapy for Parkinson’s ...

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Shares of Alumis Inc. (NASDAQ:ALMS) were selling for $16.93, up $8.62, or 103%, having traded as high as $22.30 on positive top-line results from the phase III Onward1 and Onward2 trials with ...